General MedicationsOPHTHALMICGeneric
GATIFLOXACIN
GATIFLOXACIN
Standard Dose
0.3%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary
Approval overview GATIFLOXACIN is listed in Drugs@FDA under application 203190 (ANDA).
Marketing status: None (Tentative Approval) Active ingredient GATIFLOXACIN Form and strength SOLUTION; OPHTHALMIC - 0.3% Sponsor HI-TECH PHARMACAL Submission history Latest submission status date: 2014-04-09 00:00:00.
Structured Monograph
Clinical summary
Approval overview GATIFLOXACIN is listed in Drugs@FDA under application 203190 (ANDA). Marketing status: None (Tentative Approval) Active ingredient GATIFLOXACIN Form and strength SOLUTION; OPHTHALMIC - 0.3% Sponsor HI-TECH PHARMACAL Submission history Latest submission status date: 2014-04-09 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: None (Tentative Approval)
Interaction Notes
- No interaction notes stored yet.